The Journal of Pediatrics of Korean Medicine (대한한방소아과학회지)

The Association of Korean Oriental Pediatrics (대한한방소아과학회)
권호 표지

Effect of Yanghyeoljeseuptang (YHJST) Composition on Atopic Dermatitis NC/Nga Mice Induced by DNCB(dinitrochlorobenzene)

양혈제습탕(凉血除濕湯)이 DNCB로 유도된 NC/Nga mice의 아토피 피부염에 미치는 영향

  • Park, Doo-Byoung (Department of Pediatrics, College of Oriental Medicine, Dae Jeon University) ;
  • Han, Jae-Kyung (Department of Pediatrics, College of Oriental Medicine, Dae Jeon University) ;
  • Kim, Yun-Hee (Department of Pediatrics, College of Oriental Medicine, Dae Jeon University)
  • 박두병 (대전대학교 한의과대학 소아과학교실) ;
  • 한재경 (대전대학교 한의과대학 소아과학교실) ;
  • 김윤희 (대전대학교 한의과대학 소아과학교실)
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives The purpose of this study is to investigate the effect of YHJST on atopic dermatitis in an experiment using an NC/Nga mice induced by DNCB, which has histological and clinical similarities to the condition in humans. Methods To investigate the effect of YHJST on atopic dermatitis(AD), we evaluated atopic dermatitis-like skin lesions by clinical skin index and analyzed immunological parameters in peripheral blood mononuclear cells(PBMCs) and performed skin histology in ears and dorsal skin of NC/Nga ato-mouse. Results YHJST medicines decreased Serum level of IgE, IL-6, TNF-$\alpha$. Also total number of $CD69^+$, $CD3^+$ in PBMCs, absolute cell number of $CCR3^+CD3^+$, $CD11b^+Gr-1^+$ in Dorsal skin tissue, Serum IgG1, IgM, IgG2a and IgG2b decreased significantly. Furthermore YHJST is extremely effective to histological symptoms; dermal and epidermal thickening, hyperkeratosis and inflammatory cell infiltration and suppressed histologic infiltration of $CD4^+$ & $CCR3^+$ in ear and dorsal skin lesions significantly. YHJST decreased gene-expression of IL-6, TNF-$\alpha$, CCR3, Eotaxin mRNA than that of control group. Conclusions YHJST on atopic dermatitis to atopic dermatitis NC/Nga mouse induced DNCB was incredibly effective.

Keywords

References

  1. Morren MA, Przybilla RG, Bamelis M, Heykants B, Reynaers B, Degreef H. Atopic dermatitis : triggering factors. J Am Acad Dermatol. 1994;4670-473.
  2. Leung DY, Eichenfield LF, Boguniewicz M. Atopic dermatitis, In. Fitzpatricks dermatology in general medicine. 6th ed. New York: McGraw-Hill. 2003:1180-1194.
  3. Leung DY, Soter NA. Celluar and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol. 2001;44:S1-S1201. https://doi.org/10.1067/mjd.2001.109815
  4. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J Clin Invest. 1999;103(8):1103-1111. https://doi.org/10.1172/JCI5669
  5. 洪元植 編著. 精校黃帝內經素問. 서울:東洋醫學硏究院 出版部. 1985:.72-80, 246-248.
  6. 박민철, 김진만, 홍철희, 황충연. 아토피 피부염의 동, 서의학적 문헌고찰. 대한안이비인후피부과학학회지. 2002;15(1):226-252.
  7. 馬紹堯. 現代中醫皮膚性病學. 上海:上海中醫藥大學出版社. 2001:153-160.
  8. 金起鳳, 周德瑛 主編. 中醫皮膚病學. 北京: 中國醫藥科技出版社. 1999:.193-198.
  9. 馬紹堯, 趙尙華 主編. 代中醫皮膚性病診療大全. 山西:山西科學技術出版社. 1999:475-493.
  10. Oranje AP, de Waard-van der Spek, Flora B. Atopic dermatitis. review 2000 to January 2001, Curr Opin Pediatr. 2002;14:410-413. https://doi.org/10.1097/00008480-200208000-00009
  11. 안성구, 지혜구, 황상민, 정준, 장경훈. COMMON SKIN DISEASE 진단/치료. 서울: 퍼시픽출판사. 2003:68-88.
  12. Marks R, Kilkenny M, Plunkett A, Merlin K. The prevalence of common skin conditions in Australian school students : 2. Atopic dermatitis. Br J Dermatol. 1999;140:468-473. https://doi.org/10.1046/j.1365-2133.1999.02711.x
  13. 박건수, 김정원. Cytokine patterns of acute and remission stages in patients with atopic dermatitis : expression of interferon-γ, interleukin-12. 카톨릭 대학 의학부 논문집. 1998;51:384.
  14. 박영민, 박홍진, 김태윤, 김정원. 피부과 외래환자에서 아토피 피부염의 상대빈도와 임상적 특징 및 검사 소견에 관한 연구. 대한피부과학회지. 1997;35:96.
  15. Ring J, Darsow U, Gfessor M, Vieuf D. The "Atopy patch test" in evaluating the role of aeroallergens in atopic eczema. Int Arch Allergy Immunol. 1997;13:379.
  16. 장호선. 아토피 피부염의 진단과 치료. 가정의학회지. 2002;23:831-8382.
  17. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151-160. https://doi.org/10.1016/S0140-6736(03)12193-9
  18. 오재원, 김규원, 편복양 외 18명. 1995년과2000년의 학동기와 2003년 학동전기 소아에서의 아토피피부염의 역학적 변화에 관한 전국적인 연구. 소아알레르기 및 호흡기. 2003;13(4):227-237.
  19. Abdel-Hamid KM. Atopic dermatitis in Allergy, Asthma, and Immunology Subspecialty Consult (BC. Jost, E. Friedman, KM. Abdel-Hamid, AL. Jani, Ed.). Philadelphia:LippincottWilliams & Wilins. 2003:66-73.
  20. Boguniewicz M, Beltrani VS. Atopic dermatitis and contact dermatitis in Manual of Allergy and Immunology (DC. Adelman, TB. Casale, J. Corren, Ed.). Philadelphia: LippincottWilliams & Wilins. 2002;165-186.
  21. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J, Jeannin P. Histamine polarizeshuman dendritic cells into Th2 cellpromoting effectordendritic cells. J Immunol. 2001;167:3682-3686. https://doi.org/10.4049/jimmunol.167.7.3682
  22. Cumberbatch M, Clelland K, Dearman RJ.Kimber. Impact of cutaneous IL-10 on resident epidermal Langerhans' cells and the development of polarized immuneresponses. J Immunol. 2005;175:43-50. https://doi.org/10.4049/jimmunol.175.1.43
  23. Friedmann PS. Contact sensitization and allergic contact dermatitis: Immunobiological mechanisms. Toxicol Lett. 2006;162:49-54. https://doi.org/10.1016/j.toxlet.2005.10.008
  24. Goutet M, Pepin E, Langonne I, Huguet N, Ban M. Identification of contact and respiratory sensitizersusing flow cytometry. Toxicol Appl Pharmacol. 2005;205:259-270. https://doi.org/10.1016/j.taap.2004.10.011
  25. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol. 1996;138:149-157. https://doi.org/10.1006/taap.1996.0108
  26. Hilkens CM, Kalinski P, de Boer M, Kapensberg ML. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood. 1997;90:1920-1926.
  27. Kepron MR, Chen YW, Uhr JW, Vitetta ES. IL-4 induced the specific rearrangement of gamma 1 genes on the expressed and unexpressed chromosomesof lipopolysaccharideactivated normal murine B cells. J Immunol. 1989;143:334-339.
  28. Kiekens RC, Thepen T, Oosting AJ, Bihari IC, van de Winkel JG, Bruijnzeel-Koomen CA, Knol EF. Heterogeneity within tissuespecific macrophage and dendritic cell populations during cutaneous inflammation in atopic dermatitis. Br J Dermatol. 2001;145(6):957-965. https://doi.org/10.1046/j.1365-2133.2001.04508.x
  29. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol. 1997;159:2484-2481.
  30. Leung DYM, Tharp M, Boguiewicz M. Atopic dermatitis in Fitzpatrick's Dermatology in General Medicine (IM Freedberg, AZ Eisen, K Wolff, KF Austen, LA Goldsmith, SI Katz, TB Fitzpatrick, Ed.). New York: McGraw-Hill. 1999;1464-1480.
  31. Matsumoto M, Ra C, Kawamoto K, Sato H, Itakura A, Sawada J, Ushio H, Suto H, Mitsuishi K, Hikasa Y, Matsuda H. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol. 1999;162:1056-1063.
  32. Mueller DL, Jenkins MK, Schwarz RH. Clonal expansion versus functinal clonal inactivation : A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann Rev Immunol. 1989;7:445-480. https://doi.org/10.1146/annurev.iy.07.040189.002305
  33. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL. Overexpression of IL-10 in atopic dermatitis. J Immunol. 1995;154:1956-1963.
  34. Plitnick LM, Loveless SE, Ladics GS, Holsapple MP, Selgrade MJ, Sailstad DM, Smialowicz RJ. Cytokine profiling for chemical sensitizers: Application of the ribonuclease protection assay and effect of dose. Toxicol Appl Pharmacol. 2002;179:145-154. https://doi.org/10.1006/taap.2002.9370
  35. Sikorski EE, Gerberick GF, Ryan CA, Miller CM, Ridder GM. Phenotypic analysis of lymphocyte subpopulations in lymph nodes draining the ear following exposure to contact allergens and irritants. Fund Appl Toxicol. 1996;34:25-35. https://doi.org/10.1006/faat.1996.0172
  36. Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987;236:944-947. https://doi.org/10.1126/science.3107127
  37. Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Kakinuma T, Fujita H, Asano N, Tanida Y, akugawa M, Torii H, Tamaki K. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci. 2002;30:100-107. https://doi.org/10.1016/S0923-1811(02)00065-8
  38. US Dept. Health and Human Services. Atopic dermatitis (A type of eczema). Bethesda: NIH publication. 2003:03:4272.
  39. Wiemann C, Berthold K, Heusener A, Kruger N, Seeberger A, Stropp G. Joint positive control testing in guinea pig skin sensitization tests. Reg Toxicol Pharmacol. 2002;35:14-22. https://doi.org/10.1006/rtph.2001.1503
  40. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13 : Central mediator of allergic asthma. Science. 1998;282:2258-2261. https://doi.org/10.1126/science.282.5397.2258
  41. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflmmation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clincal Invest. 1999;103:779-789. https://doi.org/10.1172/JCI5909
  42. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma : Cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol. 2003;111:227-242. https://doi.org/10.1067/mai.2003.139
  43. Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine. 2004;28:224-232. https://doi.org/10.1016/j.cyto.2004.08.007
  44. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol. 2002;167:4668-4675.
  45. Jung EM, Kim HS, Kang IJ. A 10 year follow-up childhood asthma : Potential risk factors on persistence of nonspecific bronchial hyperresponsiveness. Pediatr Allergy Respir Dis. 2002;12:82-92.
  46. Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol. 2003;112:935-943. https://doi.org/10.1016/j.jaci.2003.08.010
  47. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, et al. Effect of Th2 cytokines on chemokine expression in the lung : IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol. 1999;162:2477-2487.
  48. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, et al. IL-13 induces eosinophil recruitment into the lung by an IL-5 and eotaxin dependent mechanism. J Allergy Clin Immunol. 2001;108:594-601. https://doi.org/10.1067/mai.2001.118600
  49. Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, et al. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol. 2001;24:755-761. https://doi.org/10.1165/ajrcmb.24.6.4351
  50. Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells : a role for ERK. Am J Physiol Lung Cell Mol Physiol. 2002;282:847-852. https://doi.org/10.1152/ajplung.00245.2001
  51. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, et al. Eosinophils express functional IL-13, in eosinophilic inflammatory disease. J Immunol. 2002;169:1021-1027. https://doi.org/10.4049/jimmunol.169.2.1021
  52. Kim JT. Evaluation of inflammation in childhood asthma; Non-invasive measurement. J Korean Pediatr Soc. 2001;44:334-339.
  53. Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao XQ, Enomoto T, et al. Upregulation of IL-13 concentraion in vivo the IL-13 variant associated with bronchial asthma. J Allergy Clin Immunol. 2002;109:980-987. https://doi.org/10.1067/mai.2002.124656
  54. 巢元方 編著. 巢氏諸病源候論. 서울:대성문화사. 1992;251-253.
  55. 陳實功. 外科正宗. 天津:天津科學技術出版社. 2000;298.
  56. 肅達民 主編. 兒科病. 北京:人民衛生出版社. 2002;664-674.
  57. Abeck D, Strom K. Optimal management of atopic dermatitis. Am Clin Dermatol. 2000;1:41-46. https://doi.org/10.2165/00128071-200001010-00004
  58. Graham-Brown RA. Therapeutic in atopic dermatitis. Adv Dermatol Clin. 1990;8:747-750.
  59. 이지현 외 10인. 아토피피부염학회 보고서: 한국 아토피피부염의 치료지침. 대한피부과학회지. 2006;44(8):907-913.
  60. 이진용. 아토피피부염의 한방치료. 대한한방알레르기 및 면역학회 자료집. 2002;61-79.
  61. 전국한의과대학 本草學敎室 共編著. 本草學. 서울:도서출판 永林社. 2000;160-163, 178-179, 185-187, 190-191, 193-195, 313-314, 479-481.
  62. 임철홍. 白鮮皮가 항알레르기의 작용에 미치는 영향. 경희대학교 대학원. 1994.
  63. 이석원 외. 牧丹皮 추출물 및 EA분획의 항알러지 작용에 대한 연구. 동의병리학회지. 2001;15(4):631-635.
  64. 신광식. 生地黃 추출물이 DNCB로 유도된 생쥐의 allergy성 접촉피부염에 미치는 영향. 동국대학교 대학원. 1999.
  65. 이용숙. 金銀花-黃芩 配合이 항염증 작용에 미치는 영향. 원광대학교 대학원. 2005.
  66. 정선영. 苦蔘의 생쥐의 B-cells에 미치는 항알레르기 효과. 경희대학교 대학원. 2002.
  67. 우무륜 외. 苦蔘이 알러지성 염증 반응에 미치는 영향. 대전대학교 한의학연구소 논문집. 2006;15(2):135-148.
  68. O'Bryan L, Pinkston P, Kumaraswami V, Vijayan V, Yenokida G, Rosenberg HF, et al. Localized eosinophil degranulation mediates disease in tropical pulmonary eosinophilia. Infect Immun. 2003;71:1337-1342 https://doi.org/10.1128/IAI.71.3.1337-1342.2003
  69. Min JW, Jang AS, Park SM, Lee JH, Park SW, Park CS. Comparison of plasma eotaxin family level in aspirininduced and aspirintolerant asthma patient. Chest. 2005;128:127-132.
  70. Li J, Saito H, Crawford L, Inman MD, Cyr MM, Denburg JA. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology. 2005;114:386-396. https://doi.org/10.1111/j.1365-2567.2005.02109.x
  71. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, et al. The role of IL-13 in established allergic airway disease. J Immunol. 2002;169:6482-6489. https://doi.org/10.4049/jimmunol.169.11.6482
  72. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol. 2002;26:202-208. https://doi.org/10.1165/ajrcmb.26.2.4600
  73. Chang JY, Shin SA, Oh JW, Lee HB. Crucial factors for bronchial hyperresponsiveness in children with mild asthma. Pediatr Allergy Respir Dis. 2005;15:142-149.
  74. Shin SA, Oh JW, Lee HB, Kim NS, Lee HB. Relationship between airway hyperresposiveness and duration of asthma in children. J Asthma Allergy Clin Immunol. 2003;23:77-83.
  75. Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen K, et al. Association between an interleukin-13 promotor polymorphism and atopy. Eur J Immunogenet. 2003;30:355-359. https://doi.org/10.1046/j.1365-2370.2003.00416.x
  76. Zhou G, Zhai Y, Dong X, Zhang X, He F, Zhou K, et al. Haplotype structure and evidence for positive selection at the human IL13 locus. Mol Biol Evol. 2004;21:29-35.
  77. Baggiolini M, Dewald B, Moser B. Human chemokines: an update, Annu Rev Immunol. 1997;15:675–705. https://doi.org/10.1146/annurev.immunol.15.1.675
  78. Bartels J, Schlüter C, Richter E, Noso N, Kulke R, Christophers D, Schröder JM.Human dermal fibroblasts expression eotaxin: molecular cloning mRNA expression, and identification of eotaxin sequence variants. Biochem Biophys Res Commun. 1996;225:1045-1051. https://doi.org/10.1006/bbrc.1996.1292
  79. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187:129–134. https://doi.org/10.1084/jem.187.1.129
  80. Daugherty BL, Siciliano SJ, DeMartino JA, Malkovitz L, Sirotina A, Springer MS. Cloning expression and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996;183:2349–2354. https://doi.org/10.1084/jem.183.5.2349
  81. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotoxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 1996;2:449–456. https://doi.org/10.1038/nm0496-449
  82. Gerber BO, Zanni MP, Uguccioni M, et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol. 1997;7:836–843. https://doi.org/10.1016/S0960-9822(06)00371-X
  83. Grewe M, Bruijnzeel-Koomen C, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1998;19:359–361. https://doi.org/10.1016/S0167-5699(98)01285-7
  84. Grewe M, Gyufko K, Czech W, Krutmann J. Lesional expression of interferon-E in atopic eczema. Lancet. 1994;343:24–26.
  85. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest. 1994;94:870–876. https://doi.org/10.1172/JCI117408
  86. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol. 1980;92:44–47.
  87. Harrison PR. Molecular mechanisms involved in the regulation of gene expression during cell differentiation and development. Immunol Ser. 1990;49:411–464.
  88. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing $CD4^+$ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol. 1991;97:389-394. https://doi.org/10.1111/1523-1747.ep12480966
  89. Kitaura M, Nakajima T, Imai T, et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 1996;271:7725-7730. https://doi.org/10.1074/jbc.271.13.7725
  90. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195:10-19.
  91. Lamkhioued B, Renzi PM, Abi-Younes S, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997;159:4593-4601.
  92. Leiferman KM, Gleich, GJ. The role of eosinophils in atopic dermatitis, In: Leung, DYM eds. Atopic Dermatitis. From Pathogenesis to Treatment. Heidelberg: Springer-Verlag. 1996;145–172.
  93. Lilly CM, Nakamura H, Kesselman H, et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 1997;99:1767-1773. https://doi.org/10.1172/JCI119341
  94. Luster AD. Chemokine-chemotactic cytokines that mediate inflammation. New Engl J Med. 1998;338:436–445. https://doi.org/10.1056/NEJM199802123380706
  95. Mattoli S, Stacey MA, Sun G, Bellini A, Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun. 1997;236:299–301. https://doi.org/10.1006/bbrc.1997.6958
  96. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol. 1997;17:683-690. https://doi.org/10.1165/ajrcmb.17.6.2865
  97. Mochizuki M, Bartels J, Mallet AI,Christophers E, Schröder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol. 1998;160:60–68.
  98. Ohmen JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayedtype hypersensitivity reactions. J Immunol. 1995;154:1956–1963.
  99. Ponath PD, Qin S, Post TW, et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 1996;183:2437-2448 https://doi.org/10.1084/jem.183.6.2437
  100. Rubbert A, Combadiere C, Ostrowski M, et al. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol. 1998;160:3933–3941.
  101. Uguccioni M, Mackay CR, Ochsenberge, B, et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 1997;100:1137-1143. https://doi.org/10.1172/JCI119624
  102. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997;277:2005–2007. https://doi.org/10.1126/science.277.5334.2005
  103. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, Mudde GC. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;90:184-193. https://doi.org/10.1016/0091-6749(92)90070-I
  104. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol. 1996;80:225-235. https://doi.org/10.1006/clin.1996.0118
  105. Ying S, Robinson DS, Meng Q, et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol. 1997;27:3507-3516. https://doi.org/10.1002/eji.1830271252
  106. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med. 1995;181:2153–2159. https://doi.org/10.1084/jem.181.6.2153
  107. Ulfgren AK, Lindblad S, Klareskog L, Andresson J, Andresson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheumatic Diseases. 1995;54:654-661. https://doi.org/10.1136/ard.54.8.654
  108. Xia MQ, Qin SX, Wu LJ, Mackay CR, Hyman BT. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimers disease brains. Am J Pathol. 1998;153:3137.
  109. Yamada H, Hirai K, Miyamasu M, et al. Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun. 1997;231(2):365–368.
  110. Bronte V, Wang M, Overwijk WW, et al. Apoptotic death of $CD8^+$ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol. 1998;161(10):5313–5320.
  111. Bronte V, Chappel DB, Apolloni E, Cabrelle A, Wang M, Hwu P, Restifo NP. Unopposed production of granulocytemacrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol. 1999;162(10):5728-5737.
  112. Angulo I, de las Heras FG, Garcia-Bustos JF, Gargallo D, Munoz-Fernandez A, Fresno M. Nitric oxide-producing CD11b(+)Ly-6G (Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood. 2000;95(1):212-220.
  113. Young MR, Wright MA, Matthews JP, Malik I, Prechel M : Suppression of T cell proliferation by tumor-induced granulocytemacrophage progenitor cells producing transforming growth factor-b and nitric oxide. J Immunol. 1996;156(5):1916-1922.